Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **stratum corneum lipid matrix** is a specialized extracellular lipid structure in the outermost layer of the epidermis, mainly composed of **ceramides, cholesterol, and free fatty acids**[1][3][5][9]. These lipids are organized into multi-lamellar bilayers that fill the intercellular space between **corneocytes** (dead, keratin-rich cells), forming a critical barrier against water loss and external insults[1][4][7][9][10]. The **corneocyte envelope** refers to the highly crosslinked protein shell surrounding each corneocyte, primarily constructed from proteins such as **loricrin, involucrin, envoplakin, and periplakin**[2][4][6]. Covalently bound ω-hydroxy-ceramides form the **corneocyte lipid envelope (CLE)**, which links the protein envelope to the extracellular lipid lamellae and strengthens the cohesive barrier[2][6]. **Dysfunction or structural abnormalities** in either the lipid matrix or the protein envelope are linked to barrier diseases such as atopic dermatitis and several inherited ichthyoses[3][5][6]. This entity is a **complex, composite functional structure of the skin** that includes both molecular lipid and protein components critical for barrier function but is **not considered a single canonical therapeutic target** such as a receptor, enzyme, or transporter. Instead, it represents an integrated physical barrier and is better classified as a structural and functional complex rather than a discrete drug target[1][2][3][5][6][7][9][10]. **Note:** - This entry is flagged as "is_incorrect: true" because it refers to a complex biomaterial/structure rather than a single, canonical drug target, receptor, or molecule. - Specific drugs acting directly and selectively on this "target" do not exist; instead, barrier-supportive therapies (emollients, ceramide creams) are used for diseases implicating barrier dysfunction. - While individual components (like ceramides or corneocyte protein envelope proteins) may themselves be subjects of molecular research, the listed term conglomerates multiple distinct entities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum lipid matrix and corneocyte envelope protein.